scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/bmcsb/MelasMMWA11 |
P6179 | Dimensions Publication ID | 1029114727 |
P356 | DOI | 10.1186/1752-0509-5-107 |
P932 | PMC publication ID | 3145575 |
P698 | PubMed publication ID | 21729292 |
P5875 | ResearchGate publication ID | 51467382 |
P50 | author | Thomas S Weiss | Q39813494 |
Ioannis Melas | Q57158709 | ||
Leonidas G Alexopoulos | Q90911115 | ||
P2093 | author name string | Alexander Mitsos | |
Dimitris E Messinis | |||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context | Q21284234 | ||
Global cancer statistics, 2002 | Q27860562 | ||
Immunity, Inflammation, and Cancer | Q27861048 | ||
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
Mass spectrometry-based proteomics | Q28182890 | ||
A quantitative analysis of kinase inhibitor selectivity | Q28264038 | ||
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells | Q28282744 | ||
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data | Q28472011 | ||
ON/OFF and beyond--a boolean model of apoptosis | Q28472140 | ||
Training signaling pathway maps to biochemical data with constrained fuzzy logic: quantitative analysis of liver cell responses to inflammatory stimuli | Q28477321 | ||
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium | Q29617962 | ||
Evolving concepts of rheumatoid arthritis | Q29618020 | ||
Causal protein-signaling networks derived from multiparameter single-cell data | Q29619136 | ||
Data-driven modelling of signal-transduction networks | Q31068825 | ||
Flexible informatics for linking experimental data to mathematical models via DataRail | Q31143834 | ||
Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin-induced signaling | Q33426337 | ||
The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data | Q33491534 | ||
Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes | Q33575787 | ||
Computational modeling with forward and reverse engineering links signaling network and genomic regulatory responses: NF-kappaB signaling-induced gene expression responses in inflammation | Q33596981 | ||
Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction | Q33668279 | ||
Proteomics to study genes and genomes | Q33906818 | ||
The ins and outs of signalling | Q34311175 | ||
Physicochemical modelling of cell signalling pathways. | Q34576205 | ||
Regulation of cytokine signaling and inflammation | Q34830660 | ||
Building with a scaffold: emerging strategies for high- to low-level cellular modeling | Q35146255 | ||
The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling | Q35479152 | ||
A biological approach to computational models of proteomic networks | Q36365865 | ||
A logical analysis of T cell activation and anergy | Q36454568 | ||
Signal transduction of inflammatory cytokines and tumor development | Q36492439 | ||
Genetic screening for signal transduction in the era of network biology | Q36718781 | ||
Transforming growth factor-beta and the immune response to malignant disease | Q36987655 | ||
A review of erlotinib--an oral, selective epidermal growth factor receptor tyrosine kinase inhibitor | Q37678436 | ||
Logic-based models for the analysis of cell signaling networks | Q37708260 | ||
A multipathway phosphoproteomic signaling network model of idiosyncratic drug- and inflammatory cytokine-induced toxicity in human hepatocytes | Q37721819 | ||
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity | Q40351340 | ||
Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany | Q40496031 | ||
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells | Q40602668 | ||
E-CELL: software environment for whole-cell simulation | Q40822088 | ||
Personalizing medicine: a systems biology perspective | Q43142778 | ||
Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways | Q44127144 | ||
Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid | Q44381049 | ||
Ikappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma | Q46588782 | ||
A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. | Q51307059 | ||
Obesity, inflammatory signaling, and hepatocellular carcinoma-an enlarging link. | Q53479578 | ||
Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor | Q56689833 | ||
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction | Q74191142 | ||
A compendium of signals and responses triggered by prodeath and prosurvival cytokines | Q80394534 | ||
P304 | page(s) | 107 | |
P577 | publication date | 2011-07-05 | |
P1433 | published in | BMC Systems Biology | Q4835949 |
P1476 | title | Combined logical and data-driven models for linking signalling pathways to cellular response | |
P478 | volume | 5 |
Q30620270 | A crowd-sourcing approach for the construction of species-specific cell signaling networks |
Q41211496 | Advances and challenges in logical modeling of cell cycle regulation: perspective for multi-scale, integrative yeast cell models. |
Q37619223 | Can case study approaches speed implementation of the NRC report: "toxicity testing in the 21st century: a vision and a strategy?". |
Q59329208 | Computational Modeling and Reverse Engineering to Reveal Dominant Regulatory Interactions Controlling Osteochondral Differentiation: Potential for Regenerative Medicine |
Q36524173 | Computational model for autophagic vesicle dynamics in single cells |
Q92451177 | Connecting signaling and metabolic pathways in EGF receptor-mediated oncogenesis of glioblastoma |
Q34207814 | Construction of large signaling pathways using an adaptive perturbation approach with phosphoproteomic data |
Q28539118 | Leveraging systems biology approaches in clinical pharmacology |
Q28547548 | Network reconstruction based on proteomic data and prior knowledge of protein connectivity using graph theory |
Q35861710 | Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action |
Q34505131 | Non Linear Programming (NLP) formulation for quantitative modeling of protein signal transduction pathways |
Q34318470 | Nonparametric simulation of signal transduction networks with semi-synchronized update |
Q36268781 | Sig2GRN: a software tool linking signaling pathway with gene regulatory network for dynamic simulation |
Q35076233 | Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER Species Translation Challenge |
Search more.